Interpace Biosciences, Inc. last reported quarterly results on Oct 15, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026). It usually reports 1–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 19, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Jan 20, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 1–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 15, 2026
15 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Aug 12, 2026
43 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
9
-1.1%
|
0
+124.7%
|
0.01
+107.1%
|
|
Apr 1, 2026
1 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
9
-21.6%
|
1
-56.2%
|
0.03
-50.0%
|
|
Jan 20, 2026
20 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
9
-25.7%
|
23
+1104.5%
|
0.82
+2046.1%
|
|
Nov 12, 2025
43 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
9
-28.8%
|
1
-45.6%
|
0.03
-92.1%
|
|
Aug 8, 2025
39 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
9
-23.3%
|
-1
-126.3%
|
-0.14
-125.5%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
12
+13.1%
|
2
+132.6%
|
0.06
-62.5%
|
|
Nov 6, 2024
37 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
12
+33.6%
|
2
+1001.1%
|
0.38
+1050.0%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IDXG (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1054102
- Former names
- Interpace Diagnostics Group, Inc. (until Nov 1, 2019); PDI INC (until Dec 22, 2015); PROFESSIONAL DETAILING INC (until Nov 13, 2002)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.